Title |
Dimensions COVID-19 publications, datasets and clinical trials
|
---|---|
Published on |
figshare, March 2020
|
DOI | 10.6084/m9.figshare.11961063 |
Authors |
Resources, Dimensions |
Abstract |
This file contains all relevant publications, datasets and clinical trials from Dimensions that are related to COVID-19. The content has been exported from Dimensions using a query in the openly accessible Dimensions application, which you can access at https://covid-19.dimensions.ai/. Dimensions is updated once every 24 hours, so the latest research can be viewed alongside existing information. With its range of research outputs including datasets and clinical trials, both of which are just as important as journal articles in the face of a potential pandemic, Dimensions is a one-stop shop for all COVID-19 related information. Please share this information with anyone you think would benefit from it. If you have any suggestions as to how we can improve our search terms to maximise the volume of research related to COVID-19, please contact us at [email protected]. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 26 | 15% |
United States | 21 | 12% |
Spain | 7 | 4% |
Peru | 6 | 4% |
Indonesia | 5 | 3% |
Germany | 4 | 2% |
France | 4 | 2% |
Colombia | 4 | 2% |
Canada | 4 | 2% |
Other | 31 | 18% |
Unknown | 59 | 35% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 118 | 69% |
Scientists | 26 | 15% |
Science communicators (journalists, bloggers, editors) | 24 | 14% |
Practitioners (doctors, other healthcare professionals) | 3 | 2% |